Lataa...
Pretherapeutic (68)Ga-PSMA-617 PET may indicate the dosimetry of (177)Lu-PSMA-617 and (177)Lu-EB-PSMA-617 in main organs and tumor lesions
AIM: Combined (68)Ga-PSMA-617 positron emission tomography (PET) imaging and (177)Lu-PSMA-617 therapy is a precise targeted theranostic approach for patients with metastatic castration-resistant prostate cancer (mCRPC). The purpose of this study was to determine whether pretherapeutic standard uptak...
Tallennettuna:
| Julkaisussa: | Clin Nucl Med |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502681/ https://ncbi.nlm.nih.gov/pubmed/30985422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLU.0000000000002575 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|